IBUPROFEN, PSEUDOEPHEDRINE HYDROCHLORIDE

IBUPROFEN, PSEUDOEPHEDRINE HYDROCHLORIDE was reported 1252 times

IBUPROFEN, PSEUDOEPHEDRINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 POSTPARTUM ANXIETY 1 0.0500
1 COUGH DECREASED 3 0.0226
2 NUMB CHIN SYNDROME 1 0.0189
3 MONONUCLEOSIS HETEROPHILE TEST POSITIVE 1 0.0185
4 DEHYDROEPIANDROSTERONE INCREASED 1 0.0145
5 MYOCARDITIS INFECTIOUS 1 0.0127
6 ASTHMA LATE ONSET 1 0.0116
7 HYDROSALPINX 1 0.0109
8 PRODUCT PRIMARY PACKAGING ISSUE 1 0.0089
9 CAPSULE PHYSICAL ISSUE 1 0.0069
10 CARBON MONOXIDE DIFFUSING CAPACITY DECREASED 1 0.0059
11 PANCREATIC DUCT OBSTRUCTION 1 0.0056
12 EXAGGERATED STARTLE RESPONSE 1 0.0055
13 GENITAL TRACT INFLAMMATION 1 0.0050
14 PRODUCT PACKAGE ASSOCIATED INJURY 11 0.0049
15 PRODUCT DIFFICULT TO SWALLOW 5 0.0049
16 RECTAL FISSURE 3 0.0048
17 RENAL PAPILLARY NECROSIS 1 0.0047
18 VAGINAL MUCOSAL BLISTERING 1 0.0044
19 ABSENCE OF IMMEDIATE TREATMENT RESPONSE 1 0.0042
20 EAR NEOPLASM MALIGNANT 1 0.0042
21 TRACHEAL OBSTRUCTION 1 0.0038
22 GROWING PAINS 1 0.0037
23 DILATATION INTRAHEPATIC DUCT ACQUIRED 1 0.0034
24 PRODUCT SHAPE ISSUE 3 0.0032
25 CENTRAL SLEEP APNOEA SYNDROME 1 0.0031
26 URINE AMPHETAMINE POSITIVE 1 0.0030
27 BLOOD VISCOSITY DECREASED 1 0.0030
28 PRODUCT BLISTER PACKAGING ISSUE 3 0.0029
29 TONGUE EXFOLIATION 1 0.0028
30 TIME PERCEPTION ALTERED 1 0.0028
31 BREAST RECONSTRUCTION 1 0.0027
32 CAT SCRATCH DISEASE 1 0.0025
33 MANUFACTURING MATERIALS ISSUE 1 0.0025
34 VITAMIN D ABNORMAL 1 0.0024
35 CITROBACTER INFECTION 1 0.0023
36 ALLERGIC SINUSITIS 2 0.0023
37 PERINATAL DEPRESSION 1 0.0022
38 GALLBLADDER CHOLESTEROLOSIS 1 0.0022
39 INFUSION SITE HAEMATOMA 1 0.0021
40 HYPERVIGILANCE 2 0.0021
41 PRODUCT COATING ISSUE 2 0.0020
42 GASTROINTESTINAL FUNGAL INFECTION 1 0.0019
43 PRE-EXISTING CONDITION IMPROVED 12 0.0019
44 PRODUCT SIZE ISSUE 10 0.0019
45 GASTROENTERITIS ESCHERICHIA COLI 1 0.0018
46 MILK ALLERGY 1 0.0018
47 THERAPEUTIC PRODUCT EFFECT DELAYED 8 0.0018
48 BURN ORAL CAVITY 1 0.0017
49 IMMUNE RECONSTITUTION SYNDROME 2 0.0015
50 SMALL INTESTINE ULCER 1 0.0015
51 PRODUCT PACKAGING DIFFICULT TO OPEN 4 0.0015
52 FASCIITIS 1 0.0015
53 FOREIGN BODY IN RESPIRATORY TRACT 2 0.0015
54 ORAL MUCOSAL DISCOLOURATION 1 0.0015
55 ALLERGIC REACTION TO EXCIPIENT 3 0.0015
56 FOREIGN BODY 6 0.0015
57 PRECANCEROUS CONDITION 1 0.0015
58 FEELING OF RELAXATION 1 0.0015
59 CONTRAINDICATED DRUG ADMINISTERED 1 0.0014
60 FALSE NEGATIVE INVESTIGATION RESULT 1 0.0014
61 TONGUE PARALYSIS 1 0.0014
62 SMALL FIBRE NEUROPATHY 1 0.0014
63 IMPLANT SITE BRUISING 1 0.0013
64 AMPHETAMINES POSITIVE 1 0.0013
65 INDIFFERENCE 1 0.0013
66 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 1 0.0013
67 DRUG SCREEN POSITIVE 10 0.0013
68 SUPERIOR SAGITTAL SINUS THROMBOSIS 1 0.0013
69 CHRONIC HEPATITIS 1 0.0012
70 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 1 0.0012
71 PERIORBITAL PAIN 1 0.0012
72 MYCOTIC ALLERGY 1 0.0012
73 LIP PRURITUS 1 0.0012
74 MENINGITIS CRYPTOCOCCAL 2 0.0011
75 OROPHARYNGEAL CANDIDIASIS 1 0.0011
76 FIBROMA 1 0.0011
77 HAEMOCHROMATOSIS 1 0.0011
78 VAGINAL DISORDER 1 0.0010
79 HAEMOPHILUS INFECTION 1 0.0010
80 SINUS HEADACHE 6 0.0010
81 EYELID PAIN 2 0.0010
82 RENAL MASS 2 0.0010
83 NASAL INFLAMMATION 1 0.0009
84 INFUSION SITE MASS 1 0.0009
85 REACTION TO DRUG EXCIPIENTS 2 0.0009
86 TONSILLAR DISORDER 1 0.0009
87 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 26 0.0009
88 FLAT AFFECT 2 0.0009
89 OSTEOCHONDROSIS 1 0.0009
90 SINUS PAIN 2 0.0009
91 PENILE SWELLING 1 0.0008
92 STERNAL FRACTURE 1 0.0008
93 POST-ACUTE COVID-19 SYNDROME 1 0.0008
94 BLADDER DISCOMFORT 1 0.0008
95 LIP DISCOLOURATION 1 0.0008
96 PRODUCT COMPLAINT 20 0.0008
97 FEELING JITTERY 15 0.0008
98 PARANASAL SINUS HYPERSECRETION 3 0.0008
99 DACRYOSTENOSIS ACQUIRED 1 0.0008
100 POOR QUALITY DRUG ADMINISTERED 5 0.0008
101 LIP EXFOLIATION 1 0.0008
102 NASAL DISORDER 2 0.0008
103 DRUG EFFECT INCOMPLETE 27 0.0007
104 RASH MORBILLIFORM 2 0.0007
105 SUDDEN ONSET OF SLEEP 1 0.0007
106 ANTICONVULSANT DRUG LEVEL DECREASED 1 0.0007
107 GLUTEN SENSITIVITY 1 0.0007
108 MUTISM 1 0.0007
109 DARK CIRCLES UNDER EYES 1 0.0007
110 CHOKING 13 0.0007
111 HYPOAESTHESIA FACIAL 1 0.0007
112 BLOOD PRESSURE IMMEASURABLE 1 0.0007
113 THERAPEUTIC RESPONSE UNEXPECTED 29 0.0006
114 SKIN LACERATION 7 0.0006
115 ENTHESOPATHY 1 0.0006
116 NASAL DRYNESS 4 0.0006
117 FOREIGN BODY IN THROAT 2 0.0006
118 PRODUCT PACKAGING ISSUE 6 0.0006
119 THERAPEUTIC RESPONSE CHANGED 4 0.0006
120 OROPHARYNGEAL BLISTERING 1 0.0006
121 MITRAL VALVE PROLAPSE 1 0.0006
122 VEIN RUPTURE 1 0.0006
123 ENTEROBACTER INFECTION 1 0.0006
124 PRODUCT COLOUR ISSUE 3 0.0006
125 FIXED ERUPTION 1 0.0006
126 SENSITIVITY OF TEETH 1 0.0006
127 MICTURITION DISORDER 2 0.0006
128 MASTECTOMY 1 0.0006
129 NASAL OEDEMA 1 0.0006
130 SMALL INTESTINAL PERFORATION 1 0.0005
131 IMPATIENCE 1 0.0005
132 INTENTIONAL MISUSE 1 0.0005
133 NASAL SEPTUM DEVIATION 1 0.0005
134 MULTI-ORGAN DISORDER 1 0.0005
135 ENERGY INCREASED 3 0.0005
136 SUSPECTED COUNTERFEIT PRODUCT 2 0.0005
137 ANORECTAL DISORDER 1 0.0005
138 ARTERIOSPASM CORONARY 2 0.0005
139 REBOUND ATOPIC DERMATITIS 1 0.0005
140 COMPULSIVE SHOPPING 1 0.0005
141 ATRIAL TACHYCARDIA 1 0.0005
142 POOR QUALITY PRODUCT ADMINISTERED 5 0.0005
143 EXOPHTHALMOS 1 0.0005
144 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
145 INFUSION SITE BRUISING 1 0.0005
146 GASTRIC BYPASS 1 0.0005
147 GASTROINTESTINAL ULCER 1 0.0005
148 LIP SWELLING 15 0.0004
149 CALCINOSIS 1 0.0004
150 DRUG EFFECT DELAYED 2 0.0004
151 KOUNIS SYNDROME 1 0.0004
152 REACTION TO EXCIPIENT 1 0.0004
153 BREAKTHROUGH PAIN 1 0.0004
154 PULMONARY INFARCTION 1 0.0004
155 MYOPIA 1 0.0004
156 URINE FLOW DECREASED 1 0.0004
157 POOR QUALITY SLEEP 9 0.0004
158 PARAESTHESIA ORAL 6 0.0004
159 WRONG DOSE 1 0.0004
160 BREATH ODOUR 1 0.0004
161 SINUS DISORDER 8 0.0004
162 EYE SWELLING 15 0.0004
163 PAROSMIA 3 0.0004
164 DRUG TOLERANCE 2 0.0004
165 TUBERCULIN TEST POSITIVE 1 0.0004
166 ANGLE CLOSURE GLAUCOMA 1 0.0004
167 INCREASED UPPER AIRWAY SECRETION 2 0.0004
168 TEMPOROMANDIBULAR JOINT SYNDROME 1 0.0004
169 SKIN DISCOMFORT 1 0.0004
170 GAMBLING DISORDER 1 0.0004
171 PHARYNGITIS STREPTOCOCCAL 4 0.0004
172 PRODUCT TASTE ABNORMAL 5 0.0004
173 EAR CONGESTION 1 0.0004
174 GASTRIC PERFORATION 1 0.0004
175 ORAL FUNGAL INFECTION 1 0.0004
176 HYPOMENORRHOEA 1 0.0004
177 DRUG SCREEN FALSE POSITIVE 1 0.0004
178 EXPIRED PRODUCT ADMINISTERED 12 0.0004
179 JOINT LOCK 1 0.0004
180 LIP PAIN 1 0.0003
181 EYELID MARGIN CRUSTING 1 0.0003
182 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
183 EYELID OEDEMA 4 0.0003
184 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
185 DRUG ABUSER 2 0.0003
186 EYELIDS PRURITUS 1 0.0003
187 SWELLING OF EYELID 2 0.0003
188 NON-CARDIAC CHEST PAIN 1 0.0003
189 PNEUMONIA VIRAL 1 0.0003
190 EXPOSURE TO TOXIC AGENT 1 0.0003
191 CARDIAC FLUTTER 2 0.0003
192 VULVOVAGINAL DRYNESS 1 0.0003
193 COELIAC DISEASE 3 0.0003
194 LISTLESS 1 0.0003
195 PRODUCT FORMULATION ISSUE 2 0.0003
196 SKIN MASS 2 0.0003
197 PRODUCT PHYSICAL ISSUE 6 0.0003
198 WOUND DEHISCENCE 1 0.0003
199 CLOSTRIDIAL INFECTION 1 0.0003
200 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
201 REGURGITATION 1 0.0003
202 TACHYPHRENIA 1 0.0003
203 POLYMENORRHOEA 1 0.0003
204 ORAL DISCOMFORT 4 0.0003
205 EXTRASYSTOLES 2 0.0003
206 CAROTID ARTERY STENOSIS 1 0.0003
207 HANGOVER 1 0.0003
208 DUODENAL ULCER 2 0.0003
209 JAUNDICE CHOLESTATIC 1 0.0003
210 GLOSSITIS 1 0.0003
211 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
212 FRUSTRATION 1 0.0003
213 SPONDYLITIS 1 0.0003
214 ALCOHOL USE 1 0.0003
215 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
216 HYPOAESTHESIA ORAL 4 0.0003
217 MICTURITION URGENCY 3 0.0003
218 GASTRIC INFECTION 1 0.0003
219 DISSOCIATION 2 0.0003
220 FOOD ALLERGY 2 0.0003
221 APHTHOUS ULCER 2 0.0003
222 FAECES HARD 1 0.0003
223 HAEMORRHOIDS 5 0.0003
224 EPIGASTRIC DISCOMFORT 1 0.0003
225 PRODUCT USE COMPLAINT 4 0.0003
226 NASAL DISCOMFORT 2 0.0003
227 CEREBRAL ATROPHY 1 0.0003
228 VITAMIN B12 DEFICIENCY 1 0.0002
229 HOMICIDAL IDEATION 1 0.0002
230 AORTIC DISSECTION 1 0.0002
231 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
232 NASAL CONGESTION 14 0.0002
233 TONGUE DISCOMFORT 1 0.0002
234 CARDIAC FAILURE CHRONIC 1 0.0002
235 PURULENT DISCHARGE 1 0.0002
236 SHOULDER OPERATION 1 0.0002
237 MYDRIASIS 3 0.0002
238 TENSION HEADACHE 1 0.0002
239 HORDEOLUM 1 0.0002
240 FAECES DISCOLOURED 5 0.0002
241 CHAPPED LIPS 1 0.0002
242 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
243 TONGUE DISCOLOURATION 1 0.0002
244 FACIAL PAIN 2 0.0002
245 IMPLANT SITE PAIN 1 0.0002
246 SINUS CONGESTION 3 0.0002
247 LIP DRY 2 0.0002
248 IMPAIRED GASTRIC EMPTYING 3 0.0002
249 EXOSTOSIS 2 0.0002
250 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
251 LOCALISED OEDEMA 1 0.0002
252 SWELLING FACE 14 0.0002
253 VAGINAL INFECTION 1 0.0002
254 DRUG INEFFECTIVE 279 0.0002
255 DYSPHAGIA 20 0.0002
256 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
257 DISEASE RECURRENCE 10 0.0002
258 HORMONE LEVEL ABNORMAL 1 0.0002
259 PALPITATIONS 24 0.0002
260 DRUG EFFECT DECREASED 11 0.0002
261 NASAL POLYPS 1 0.0002
262 HEART RATE INCREASED 20 0.0002
263 RHINORRHOEA 13 0.0002
264 EPISTAXIS 15 0.0002
265 EUPHORIC MOOD 2 0.0002
266 INITIAL INSOMNIA 2 0.0002
267 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
268 INSOMNIA 51 0.0002
269 RESTLESSNESS 7 0.0002
270 PRODUCT ODOUR ABNORMAL 2 0.0002
271 SENSITIVITY TO WEATHER CHANGE 1 0.0002
272 RENAL PAIN 2 0.0002
273 ANORECTAL DISCOMFORT 1 0.0002
274 ANAL FISSURE 1 0.0002
275 BRUXISM 1 0.0002
276 ERYTHEMA OF EYELID 1 0.0002
277 ASPIRATION 2 0.0002
278 JAW DISORDER 1 0.0002
279 CHOKING SENSATION 1 0.0002
280 HEART RATE ABNORMAL 1 0.0002
281 SOMNOLENCE 36 0.0002
282 SNEEZING 4 0.0002
283 OCULAR DISCOMFORT 2 0.0002
284 HYPERSENSITIVITY 33 0.0002
285 GENERALISED ERYTHEMA 1 0.0002
286 DYSGEUSIA 13 0.0002
287 NEUROLOGICAL SYMPTOM 1 0.0002
288 VISUAL DISTURBANCE 1 0.0002
289 GASTRIC HAEMORRHAGE 2 0.0002
290 PRODUCT SUBSTITUTION ISSUE 10 0.0002
291 METABOLIC DISORDER 1 0.0002
292 HYPERCHLORHYDRIA 1 0.0002
293 DECREASED INTEREST 1 0.0002
294 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
295 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
296 CHOLANGITIS 1 0.0002
297 INFUSION SITE EXTRAVASATION 1 0.0002
298 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
299 PHOTOPHOBIA 3 0.0002
300 HEAD INJURY 5 0.0002
301 PRODUCT USE IN UNAPPROVED INDICATION 39 0.0002
302 INJECTION SITE IRRITATION 2 0.0002
303 SINUSITIS 16 0.0002
304 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
305 HAEMOGLOBIN ABNORMAL 1 0.0002
306 URTICARIA 26 0.0002
307 INCOHERENT 1 0.0002
308 RESPIRATORY TRACT INFECTION 4 0.0002
309 TENDON DISORDER 1 0.0002
310 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
311 PRODUCT PREPARATION ISSUE 1 0.0002
312 FEELING ABNORMAL 36 0.0002
313 EYE HAEMORRHAGE 2 0.0001
314 POST-TRAUMATIC STRESS DISORDER 1 0.0001
315 INTENTIONAL PRODUCT MISUSE 13 0.0001
316 WRONG PRODUCT ADMINISTERED 1 0.0001
317 ANGER 5 0.0001
318 LIMB INJURY 4 0.0001
319 CROHN'S DISEASE 1 0.0001
320 JOINT EFFUSION 1 0.0001
321 FORMICATION 1 0.0001
322 HUNGER 2 0.0001
323 DIVERTICULUM 1 0.0001
324 RETCHING 3 0.0001
325 BRONCHOSPASM 2 0.0001
326 PANIC REACTION 1 0.0001
327 TONGUE DISORDER 1 0.0001
328 ANOSMIA 2 0.0001
329 UTERINE LEIOMYOMA 1 0.0001
330 ORAL DISORDER 1 0.0001
331 FEELING DRUNK 1 0.0001
332 SUNBURN 1 0.0001
333 NERVOUSNESS 7 0.0001
334 APHASIA 4 0.0001
335 ABDOMINAL PAIN UPPER 27 0.0001
336 INSURANCE ISSUE 2 0.0001
337 SWOLLEN TONGUE 4 0.0001
338 SLEEP DISORDER 9 0.0001
339 FURUNCLE 1 0.0001
340 BLOOD ALBUMIN DECREASED 1 0.0001
341 GINGIVAL PAIN 1 0.0001
342 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
343 HIP FRACTURE 4 0.0001
344 BLOOD PRESSURE INCREASED 19 0.0001
345 STENT PLACEMENT 1 0.0001
346 FRUSTRATION TOLERANCE DECREASED 1 0.0001
347 ABNORMAL FAECES 1 0.0001
348 HICCUPS 1 0.0001
349 HAIR DISORDER 1 0.0001
350 MENSTRUAL DISORDER 1 0.0001
351 AGEUSIA 3 0.0001
352 ABDOMINAL DISCOMFORT 20 0.0001
353 DRUG USE DISORDER 1 0.0001
354 INFUSION SITE ERYTHEMA 1 0.0001
355 FACE OEDEMA 2 0.0001
356 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
357 ANAPHYLACTIC SHOCK 3 0.0001
358 PARANOIA 2 0.0001
359 PSYCHOLOGICAL TRAUMA 1 0.0001
360 RASH GENERALISED 3 0.0001
361 DEAFNESS 3 0.0001
362 LOCAL SWELLING 2 0.0001
363 NASOPHARYNGITIS 21 0.0001
364 GROIN PAIN 1 0.0001
365 COLD SWEAT 2 0.0001
366 PRODUCT COMMUNICATION ISSUE 1 0.0001
367 LUNG INFILTRATION 1 0.0001
368 DIZZINESS 56 0.0001
369 WRONG DRUG ADMINISTERED 1 0.0001
370 GASTROENTERITIS VIRAL 2 0.0001
371 TOOTHACHE 2 0.0001
372 OPTIC NEURITIS 1 0.0001
373 CONDITION AGGRAVATED 33 0.0001
374 GRAND MAL CONVULSION 1 0.0001
375 PRODUCT DISTRIBUTION ISSUE 1 0.0001
376 BACTERIAL INFECTION 2 0.0001
377 ARTERIOSCLEROSIS 1 0.0001
378 HALLUCINATION 8 0.0001
379 SPUTUM DISCOLOURED 1 0.0001
380 BLOOD URINE PRESENT 2 0.0001
381 SLEEP APNOEA SYNDROME 2 0.0001
382 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
383 DRUG INTOLERANCE 10 0.0001
384 EAR PAIN 2 0.0001
385 ORAL HERPES 2 0.0001
386 WHEEZING 6 0.0001
387 HAEMATOCRIT DECREASED 2 0.0001
388 VAGINAL DISCHARGE 1 0.0001
389 HYPOTHERMIA 1 0.0001
390 EXTRA DOSE ADMINISTERED 4 0.0001
391 PSORIATIC ARTHROPATHY 4 0.0001
392 EYELID PTOSIS 1 0.0001
393 DRY THROAT 1 0.0001
394 SLUGGISHNESS 1 0.0001
395 EAR DISCOMFORT 1 0.0001
396 OROPHARYNGEAL PAIN 9 0.0001
397 INFLUENZA LIKE ILLNESS 8 0.0001
398 TEMPERATURE INTOLERANCE 1 0.0001
399 POOR VENOUS ACCESS 1 0.0001
400 VENTRICULAR EXTRASYSTOLES 1 0.0001
401 EYE DISCHARGE 1 0.0001
402 FOLLICULITIS 1 0.0001
403 SCRATCH 1 0.0001
404 CYSTITIS 3 0.0001
405 MOOD SWINGS 3 0.0001
406 HEREDITARY ANGIOEDEMA 1 0.0001
407 BREAST CANCER METASTATIC 1 0.0001
408 UNEVALUABLE EVENT 7 0.0001
409 PULMONARY THROMBOSIS 1 0.0001
410 EYE DISORDER 3 0.0001
411 DEPENDENCE 5 0.0001
412 GASTROINTESTINAL PAIN 1 0.0001
413 FOOT DEFORMITY 1 0.0001
414 VIRAL INFECTION 3 0.0001
415 SKIN DISORDER 3 0.0001
416 NERVE INJURY 1 0.0001
417 MALNUTRITION 1 0.0001
418 THROAT IRRITATION 4 0.0001
419 BLISTER 5 0.0001
420 BLOOD CALCIUM DECREASED 1 0.0001
421 MYOCARDIAL ISCHAEMIA 1 0.0001
422 HEADACHE 55 0.0001
423 DERMATITIS CONTACT 1 0.0001
424 MYOCARDITIS 1 0.0001
425 MUSCLE TWITCHING 2 0.0001
426 NIGHTMARE 3 0.0001
427 MADAROSIS 1 0.0001
428 BLOOD CHOLESTEROL INCREASED 4 0.0001
429 SWELLING 8 0.0001
430 PRODUCT USE ISSUE 16 0.0001
431 BLOOD IRON DECREASED 1 0.0001
432 PRODUCT PRESCRIBING ERROR 2 0.0001
433 CHOLECYSTITIS 1 0.0001
434 PRODUCTIVE COUGH 4 0.0001
435 CRYING 3 0.0001
436 MENTAL IMPAIRMENT 2 0.0001
437 PANIC ATTACK 3 0.0001
438 NEURALGIA 2 0.0001
439 INFLUENZA 9 0.0001
440 PHARYNGITIS 1 0.0001
441 HAIR COLOUR CHANGES 1 0.0001
442 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
443 SECRETION DISCHARGE 1 0.0001
444 COVID-19 14 0.0001
445 DYSARTHRIA 3 0.0001
446 NAUSEA 63 0.0001
447 TREMOR 13 0.0001
448 DEVICE DEPLOYMENT ISSUE 1 0.0001
449 HEPATITIS 2 0.0001
450 ROTATOR CUFF SYNDROME 1 0.0001
451 ILLNESS 8 0.0001
452 HYPERHIDROSIS 10 0.0001
453 INFUSION SITE PAIN 1 0.0001
454 ANOREXIA 1 0.0001
455 UNRESPONSIVE TO STIMULI 2 0.0001
456 ANXIETY 22 0.0001
457 PLATELET COUNT INCREASED 1 0.0001
458 HAEMORRHAGE 8 0.0001
459 SEDATION 2 0.0001
460 ARTHRITIS 6 0.0001
461 ANHEDONIA 2 0.0001
462 ORAL CANDIDIASIS 1 0.0001
463 IMMUNE SYSTEM DISORDER 1 0.0001
464 SARS-COV-2 TEST POSITIVE 1 0.0001
465 DRUG INTERACTION 12 0.0001
466 HAIR TEXTURE ABNORMAL 1 0.0001
467 MALIGNANT MELANOMA 1 0.0001
468 DYSPNOEA 42 0.0001
469 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 15 0.0001
470 DRY MOUTH 6 0.0001
471 THROAT TIGHTNESS 2 0.0001
472 PRODUCT QUALITY ISSUE 10 0.0001
473 GINGIVAL BLEEDING 1 0.0001
474 CORONARY ARTERY OCCLUSION 1 0.0001
475 PRURITUS 28 0.0001
476 PERIPHERAL COLDNESS 1 0.0001
477 HAEMATOCHEZIA 4 0.0001
478 ABNORMAL DREAMS 2 0.0001
479 ATRIAL FIBRILLATION 7 0.0001
480 ROAD TRAFFIC ACCIDENT 3 0.0001
481 NECK PAIN 4 0.0001
482 MASS 1 0.0001
483 BLOOD TEST ABNORMAL 1 0.0001
484 EYE PAIN 4 0.0001
485 HYPERTENSION 15 0.0001
486 SEASONAL ALLERGY 1 0.0001
487 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
488 LOSS OF CONSCIOUSNESS 9 0.0001
489 VOMITING 33 0.0001
490 ANGINA PECTORIS 2 0.0001
491 HYPERSOMNIA 2 0.0001
492 MOBILITY DECREASED 5 0.0001
493 OVERDOSE 15 0.0001
494 BALANCE DISORDER 6 0.0001
495 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
496 APATHY 1 0.0001
497 MALAISE 30 0.0001
498 ANGIOEDEMA 3 0.0001
499 LABORATORY TEST ABNORMAL 2 0.0001
500 COUGH 19 0.0001
501 PSYCHOTIC DISORDER 2 0.0001
502 IMMUNODEFICIENCY 1 0.0001
503 HAEMORRHAGE INTRACRANIAL 1 0.0001
504 RESPIRATORY DISORDER 2 0.0001
505 HYPOAESTHESIA 10 0.0001
506 ECONOMIC PROBLEM 1 0.0001
507 VERTIGO 4 0.0001
508 SKIN DISCOLOURATION 3 0.0001
509 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
510 THYROID DISORDER 1 0.0001
511 EMOTIONAL DISORDER 2 0.0001
512 CHEST PAIN 12 0.0001
513 MUSCULOSKELETAL CHEST PAIN 1 0.0001
514 ANKLE FRACTURE 1 0.0001
515 LUNG INFECTION 1 0.0001
516 CARDIAC DISORDER 6 0.0001
517 HALLUCINATION, AUDITORY 1 0.0001
518 MIGRAINE 6 0.0001
519 RASH ERYTHEMATOUS 3 0.0001
520 SCIATICA 1 0.0001
521 SENSORY DISTURBANCE 1 0.0001
522 DRUG DEPENDENCE 10 0.0001
523 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
524 ASTHMA 7 0.0001
525 MUSCLE TIGHTNESS 1 0.0001
526 BLOOD POTASSIUM INCREASED 1 0.0001
527 METASTASES TO BONE 1 0.0001
528 VENTRICULAR TACHYCARDIA 1 0.0001
529 DRUG LEVEL INCREASED 1 0.0001
530 INFUSION RELATED REACTION 4 0.0001
531 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
532 DRY EYE 3 0.0001
533 FUNGAL INFECTION 2 0.0001
534 DEHYDRATION 8 0.0001
535 URINARY RETENTION 2 0.0001
536 DRY SKIN 8 0.0001
537 EYE PRURITUS 2 0.0001
538 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
539 METRORRHAGIA 1 0.0001
540 MEMORY IMPAIRMENT 8 0.0001
541 MUSCULOSKELETAL DISCOMFORT 1 0.0001
542 RASH MACULAR 2 0.0001
543 MUSCULOSKELETAL STIFFNESS 5 0.0001
544 BURNING SENSATION 4 0.0001
545 AMENORRHOEA 1 0.0001
546 HEART RATE DECREASED 2 0.0001
547 METASTASES TO LIVER 1 0.0001
548 HEAD DISCOMFORT 1 0.0001
549 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
550 GALLBLADDER DISORDER 1 0.0001
551 THIRST 1 0.0001
552 GOUT 1 0.0001
553 SYNOVITIS 1 0.0001
554 RASH PRURITIC 3 0.0001
555 OSTEOMYELITIS 1 0.0001
556 PELVIC PAIN 1 0.0001
557 SUICIDAL IDEATION 5 0.0001
558 MUSCLE SPASMS 10 0.0001
559 DYSURIA 2 0.0001
560 ANAPHYLACTIC REACTION 3 0.0001
561 BLOOD GLUCOSE ABNORMAL 1 0.0001
562 MIDDLE INSOMNIA 1 0.0001
563 DYSPNOEA EXERTIONAL 2 0.0001
564 HOT FLUSH 4 0.0001
565 INTESTINAL OBSTRUCTION 2 0.0001
566 FLATULENCE 3 0.0001
567 RASH 23 0.0001
568 FOOT FRACTURE 1 0.0001
569 DEPRESSION 12 0.0001
570 GASTRIC ULCER 1 0.0001
571 PROTEINURIA 1 0.0001
572 CONVULSION 3 0.0001
573 HERPES ZOSTER 3 0.0001
574 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
575 GLAUCOMA 1 0.0001
576 HERNIA 1 0.0001
577 ERUCTATION 1 0.0001
578 VISION BLURRED 7 0.0001
579 KIDNEY INFECTION 1 0.0001
580 DYSPEPSIA 5 0.0001
581 DISABILITY 1 0.0001
582 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
583 DISORIENTATION 2 0.0001
584 CONSTIPATION 11 0.0001
585 UPPER LIMB FRACTURE 1 0.0001
586 SPINAL FRACTURE 1 0.0000
587 THROMBOSIS 4 0.0000
588 CONFUSIONAL STATE 8 0.0000
589 THERAPEUTIC RESPONSE DECREASED 3 0.0000
590 FEEDING DISORDER 1 0.0000
591 DYSKINESIA 2 0.0000
592 BODY TEMPERATURE INCREASED 1 0.0000
593 RIB FRACTURE 1 0.0000
594 POLLAKIURIA 2 0.0000
595 INTENTIONAL DRUG MISUSE 1 0.0000
596 HALLUCINATION, VISUAL 1 0.0000
597 DECREASED APPETITE 11 0.0000
598 OSTEOARTHRITIS 2 0.0000
599 EATING DISORDER 1 0.0000
600 JOINT INJURY 1 0.0000
601 IMPAIRED WORK ABILITY 1 0.0000
602 IRRITABLE BOWEL SYNDROME 1 0.0000
603 LIVER FUNCTION TEST INCREASED 1 0.0000
604 HYPOACUSIS 2 0.0000
605 PRURITUS GENERALISED 1 0.0000
606 DEEP VEIN THROMBOSIS 3 0.0000
607 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
608 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
609 VAGINAL HAEMORRHAGE 2 0.0000
610 MENTAL DISORDER 2 0.0000
611 PRODUCT DOSE OMISSION 3 0.0000
612 TACHYCARDIA 4 0.0000
613 TOOTH DISORDER 1 0.0000
614 RASH PAPULAR 1 0.0000
615 THERAPY NON-RESPONDER 2 0.0000
616 CHROMATURIA 1 0.0000
617 HEART RATE IRREGULAR 1 0.0000
618 NEPHROLITHIASIS 2 0.0000
619 TINNITUS 2 0.0000
620 SHOCK 1 0.0000
621 PAIN 26 0.0000
622 OCULAR HYPERAEMIA 2 0.0000
623 PULMONARY EMBOLISM 4 0.0000
624 NEUROPATHY PERIPHERAL 4 0.0000
625 GAIT DISTURBANCE 8 0.0000
626 BLOOD PRESSURE FLUCTUATION 1 0.0000
627 DIABETIC KETOACIDOSIS 1 0.0000
628 JOINT SWELLING 5 0.0000
629 PRESYNCOPE 1 0.0000
630 UNDERDOSE 3 0.0000
631 CEREBRAL INFARCTION 1 0.0000
632 AGITATION 3 0.0000
633 BRONCHITIS 3 0.0000
634 OSTEONECROSIS OF JAW 1 0.0000
635 HAEMATEMESIS 1 0.0000
636 DIABETES MELLITUS 3 0.0000
637 INFLAMMATION 2 0.0000
638 DIARRHOEA 25 0.0000
639 EXPOSURE VIA SKIN CONTACT 1 0.0000
640 FATIGUE 30 0.0000
641 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
642 DIPLOPIA 1 0.0000
643 ARTHRALGIA 16 0.0000
644 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
645 ABDOMINAL DISTENSION 4 0.0000
646 MUCOSAL INFLAMMATION 1 0.0000
647 SPEECH DISORDER 2 0.0000
648 JOINT STIFFNESS 1 0.0000
649 BREAST CANCER FEMALE 1 0.0000
650 MENSTRUATION IRREGULAR 1 0.0000
651 FEAR 1 0.0000
652 DISTURBANCE IN ATTENTION 2 0.0000
653 PALLOR 1 0.0000
654 MENTAL STATUS CHANGES 1 0.0000
655 COMPLETED SUICIDE 3 0.0000
656 ARTHROPATHY 2 0.0000
657 FEELING COLD 1 0.0000
658 WEIGHT DECREASED 10 0.0000
659 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
660 INTENTIONAL DOSE OMISSION 1 0.0000
661 RED BLOOD CELL COUNT DECREASED 1 0.0000
662 LETHARGY 2 0.0000
663 PYREXIA 12 0.0000
664 SEIZURE 4 0.0000
665 BACK PAIN 8 0.0000
666 BONE PAIN 2 0.0000
667 SURGERY 2 0.0000
668 PAIN IN EXTREMITY 10 0.0000
669 ACUTE MYOCARDIAL INFARCTION 1 0.0000
670 URINARY INCONTINENCE 1 0.0000
671 CATARACT 2 0.0000
672 IRRITABILITY 2 0.0000
673 BLOOD POTASSIUM DECREASED 1 0.0000
674 LACRIMATION INCREASED 1 0.0000
675 STOMATITIS 2 0.0000
676 ILL-DEFINED DISORDER 2 0.0000
677 EPILEPSY 1 0.0000
678 INJECTION SITE RASH 1 0.0000
679 PERIPHERAL SWELLING 5 0.0000
680 LIMB DISCOMFORT 1 0.0000
681 NERVOUS SYSTEM DISORDER 1 0.0000
682 PARAESTHESIA 5 0.0000
683 HYPOTHYROIDISM 1 0.0000
684 INTENTIONAL OVERDOSE 2 0.0000
685 NIGHT SWEATS 1 0.0000
686 LACTIC ACIDOSIS 1 0.0000
687 INCORRECT DOSE ADMINISTERED 7 0.0000
688 BLOOD CREATININE INCREASED 2 0.0000
689 PSORIASIS 4 0.0000
690 ALOPECIA 6 0.0000
691 CHOLELITHIASIS 1 0.0000
692 SYNCOPE 3 0.0000
693 GAIT INABILITY 1 0.0000
694 TYPE 2 DIABETES MELLITUS 1 0.0000
695 CEREBROVASCULAR ACCIDENT 5 0.0000
696 HEPATIC ENZYME INCREASED 2 0.0000
697 CHEST DISCOMFORT 3 0.0000
698 ERYTHEMA 6 0.0000
699 GASTRIC DISORDER 1 0.0000
700 DELIRIUM 1 0.0000
701 NEOPLASM PROGRESSION 1 0.0000
702 HYPERKALAEMIA 1 0.0000
703 INJURY 2 0.0000
704 LYMPHADENOPATHY 1 0.0000
705 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
706 CEREBRAL HAEMORRHAGE 1 0.0000
707 SKIN BURNING SENSATION 2 0.0000
708 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
709 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
710 ACCIDENTAL OVERDOSE 1 0.0000
711 FALL 9 0.0000
712 COLITIS 1 0.0000
713 ACNE 2 0.0000
714 CHILLS 3 0.0000
715 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
716 ABNORMAL BEHAVIOUR 1 0.0000
717 OFF LABEL USE 22 0.0000
718 INJECTION SITE BRUISING 2 0.0000
719 EMOTIONAL DISTRESS 3 0.0000
720 OEDEMA PERIPHERAL 3 0.0000
721 NEUTROPHIL COUNT DECREASED 1 0.0000
722 ASTHENIA 9 0.0000
723 WITHDRAWAL SYNDROME 1 0.0000
724 PRODUCT DOSE OMISSION ISSUE 7 0.0000
725 RENAL FAILURE ACUTE 1 0.0000
726 RECTAL HAEMORRHAGE 1 0.0000
727 SEPTIC SHOCK 1 0.0000
728 MYOCARDIAL INFARCTION 4 0.0000
729 LIVER DISORDER 1 0.0000
730 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
731 GASTROINTESTINAL DISORDER 2 0.0000
732 DEVICE ISSUE 2 0.0000
733 HYPOKALAEMIA 1 0.0000
734 PNEUMONIA 7 0.0000
735 ABDOMINAL PAIN 5 0.0000
736 RENAL DISORDER 1 0.0000
737 COGNITIVE DISORDER 1 0.0000
738 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
739 ARRHYTHMIA 1 0.0000
740 CONTUSION 2 0.0000
741 INFECTION 3 0.0000
742 AGGRESSION 1 0.0000
743 HAEMOGLOBIN DECREASED 2 0.0000
744 MUSCULOSKELETAL PAIN 1 0.0000
745 DEPRESSED MOOD 1 0.0000
746 BRADYCARDIA 1 0.0000
747 PLATELET COUNT DECREASED 2 0.0000
748 OEDEMA 1 0.0000
749 TREATMENT NONCOMPLIANCE 1 0.0000
750 DRUG DOSE OMISSION 3 0.0000
751 MEDICATION ERROR 1 0.0000
752 PANCYTOPENIA 1 0.0000
753 WEIGHT INCREASED 4 0.0000
754 MYALGIA 3 0.0000
755 MUSCULAR WEAKNESS 2 0.0000
756 EYE IRRITATION 1 0.0000
757 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
758 NO ADVERSE EVENT 3 0.0000
759 SUICIDE ATTEMPT 1 0.0000
760 DISCOMFORT 1 0.0000
761 FEELING HOT 1 0.0000
762 VISUAL IMPAIRMENT 2 0.0000
763 INJECTION SITE ERYTHEMA 2 0.0000
764 BLOOD GLUCOSE INCREASED 3 0.0000
765 AMNESIA 1 0.0000
766 NEOPLASM MALIGNANT 1 0.0000
767 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
768 INJECTION SITE REACTION 1 0.0000
769 RESPIRATORY FAILURE 1 0.0000
770 CHRONIC KIDNEY DISEASE 1 0.0000
771 INJECTION SITE SWELLING 1 0.0000
772 INJECTION SITE PAIN 4 0.0000
773 INJECTION SITE HAEMORRHAGE 1 0.0000
774 PROSTATE CANCER 1 0.0000
775 CARDIAC ARREST 1 0.0000
776 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
777 RENAL IMPAIRMENT 1 0.0000
778 TOXICITY TO VARIOUS AGENTS 2 0.0000
779 SKIN EXFOLIATION 1 0.0000
780 DRUG WITHDRAWAL SYNDROME 1 0.0000
781 SEPSIS 1 0.0000
782 THROMBOCYTOPENIA 1 0.0000
783 RHEUMATOID ARTHRITIS 1 0.0000
784 DISEASE PROGRESSION 1 0.0000
785 ACUTE KIDNEY INJURY 1 0.0000
786 HOSPITALISATION 1 0.0000
787 URINARY TRACT INFECTION 1 0.0000
788 HYPOTENSION 1 0.0000
789 DEATH 3 0.0000